|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/22 | |
| A61K 9/24 | |||
| A61K 31/4035 |
| (11) | Patento numeris | 2651400 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11831805.4 |
| Europos patento paraiškos padavimo data | 2011-12-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-10-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/065151 |
| Data | 2011-12-15 |
| (87) | Numeris | WO 2012/083017 |
| Data | 2012-06-21 |
| (30) | Numeris | Data | Šalis |
| 424003 P | 2010-12-16 | US |
| (72) |
CHEN, Ming, J., US
HUI, Ho-Wah, US
SHEN, Xiaole, US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | CONTROLLED RELEASE ORAL DOSAGE FORMS OF POORLY SOLUBLE DRUGS AND USES THEREOF |
| CONTROLLED RELEASE ORAL DOSAGE FORMS OF POORLY SOLUBLE DRUGS AND USES THEREOF |